dithiane has been researched along with methyl-thiohydantoin-tryptophan in 1 studies
| Studies (dithiane) | Trials (dithiane) | Recent Studies (post-2010) (dithiane) | Studies (methyl-thiohydantoin-tryptophan) | Trials (methyl-thiohydantoin-tryptophan) | Recent Studies (post-2010) (methyl-thiohydantoin-tryptophan) |
|---|---|---|---|---|---|
| 48 | 0 | 21 | 376 | 1 | 348 |
| Protein | Taxonomy | dithiane (IC50) | methyl-thiohydantoin-tryptophan (IC50) |
|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.11 | |
| Receptor-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | 0.6937 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, D; Li, H; Liang, G; Liang, Z; Rong, R; Xia, X; Xiao, H; You, M; Zeng, Z; Zhou, X | 1 |
1 other study(ies) available for dithiane and methyl-thiohydantoin-tryptophan
| Article | Year |
|---|---|
Targeting Cell Membranes, Depleting ROS by Dithiane and Thioketal-Containing Polymers with Pendant Cholesterols Delivering Necrostatin-1 for Glaucoma Treatment.
Topics: Animals; Cell Membrane; Disease Models, Animal; Glaucoma; Reactive Oxygen Species | 2022 |